MNST

Monster Beverage

$46.46

+1.95%
Nov 13, 2026
Bobby Quantitative Model
Monster Beverage Corporation is a global leader in the energy drink category within the nonalcoholic ready-to-drink beverage market, marketing brands such as Monster Energy, Monster Ultra, Java Monster, Juice Monster, Reign, NOS, Bang, and Burn, while also operating a small alcohol business following its 2022 craft brewer acquisition; it outsources manufacturing to co-packers and distribution to the global Coca-Cola bottling system under a 20-year agreement, with Coca-Cola holding a 20.9% equity stake. The company is best characterized as the category incumbent and share leader in energy drinks, with roughly two-thirds of revenue historically generated in the US and Canada and a brand portfolio that spans value to premium tiers. The current investor debate centers on whether Monster can sustain growth that looks unusually fast for a mature beverage company — international sales are surging (up 34.6% and now roughly 46% of revenue per recent coverage) even as the domestic energy category shows signs of deceleration and intensifying competition from challengers like Celsius. A 2-for-1 stock split completed in August 2026, a premium valuation near 40x trailing earnings, and a recent Q3 print that showed 16.65% revenue growth have kept the stock in focus, with bulls pointing to international runway and bears flagging multiple compression risk and slowing North American momentum.

People also watch

The Coca-Cola Company

The Coca-Cola Company

KO

Analysis
PepsiCo

PepsiCo

PEP

Analysis
Keurig Dr Pepper

Keurig Dr Pepper

KDP

Analysis
Coca-Cola Consolidated, Inc.

Coca-Cola Consolidated, Inc.

COKE

Analysis
Celsius Holdings, Inc. Common Stock

Celsius Holdings, Inc. Common Stock

CELH

Analysis

BobbyInvestment Opinion: Should I buy MNST Today?

Rating: Hold. Monster is a high-quality, zero-debt compounder growing revenue 16.65% with 54.65% gross margins and $1.921 billion in TTM free cash flow, but at 39.12x trailing and 35.67x forward earnings with an average analyst target of $50.13 offering only ~7.9% upside from $46.46, the risk/reward is balanced rather than compelling. The consensus 'buy' rating (mean 2.04, 14 Buy / 10 Hold / 1 Sell) is constructive but the heavy Hold contingent and reiteration-only institutional activity confirm the market sees the stock as fairly valued after its 30.73% one-year run.

The supporting evidence is genuinely strong: revenue grew 16.65% YoY to $2.563 billion in Q3 2026 on 34.6% international growth (now ~46% of revenue), gross margin held in a 54.6%-55.9% band across four quarters, TTM net margin is 22.97% with ROE of 23.08%, debt-to-equity is 0.0 with a 3.70 current ratio and $2.148 billion in cash, and FCF of $1.921 billion covers $31.6 million quarterly capex more than 17x. The PEG of 1.28 is the most reassuring valuation datapoint, but the 9.02x PS and 27.94x EV/EBITDA represent a roughly 40-100%+ premium to large-cap beverage peers, and the 39.12x PE sits in the upper-middle of its own 30.4x-46.9x two-year band.

The biggest risks that could invalidate the thesis are (1) operating margin compression — down from 31.02% in Q1 2026 to 28.04% in Q3, with Q3 net income of $568.4 million below Q2's $584.5 million despite higher revenue; (2) US category deceleration and Celsius-driven competition against a two-thirds US/Canada revenue base; and (3) international growth cooling from 34.6% toward the high teens, which would force multiple compression. This Hold would upgrade to Buy if the stock pulled back toward the $41.62 September trough (implying ~30x forward EPS of $1.82) or if operating margins re-expanded above 30% while international growth held above 30%; it would downgrade to Sell if operating margin fell below 27% or international growth decelerated below 20%. Verdict: fairly valued relative to its own history and at a defensible but full premium to peers — a quality business priced for continued success, not a bargain.

Sign up to view all

MNST 12-Month Price Forecast

Monster is a fundamentally excellent business — zero debt, 54.65% gross margins, 22.97% TTM net margin, $1.921 billion in TTM free cash flow, and 16.65% revenue growth that is unusually fast for a mature beverage company — but the stock already reflects much of that success at 39.12x trailing earnings. The bull case rests on international growth above 30% persisting long enough to grow into the multiple, while the bear case is almost entirely about valuation and deceleration rather than business deterioration, and the ~7.9% implied upside to the $50.13 average target alongside a 10-of-23 Hold contingent confirms the market sees balanced risk/reward. The single most important variable is whether international growth holds above 30% while operating margin stabilizes near 28%-29%; if both happen, the PEG of 1.28 supports the multiple and the stock grinds toward the $52-$57 range, but if either falters, a 39x multiple on high-single-digit growth de-rates toward the $37-$41.62 zone. I would upgrade to bullish if the stock pulled back toward the $41.62 September trough (roughly 30x forward EPS) or if Q4 showed operating margin re-expanding above 30% with international growth intact, and I would downgrade to bearish if operating margin fell below 27% or international growth decelerated below 20%. With a 0.511 beta and a -17.7% max drawdown, the downside is cushioned relative to the market, but the asymmetric upside that made the stock a 30.73% one-year outperformer is largely behind it.

Historical Price
Current Price $46.46
Average Target $50.00
High Target $57.00
Low Target $37.00

Wall Street consensus

Most Wall Street analysts maintain a constructive view on Monster Beverage's 12-month outlook, with a consensus price target around $50.13 and implied upside of +7.9% versus the current price.

Average Target

$50.13

25 analysts

Implied Upside

+7.9%

vs. current price

Analyst Count

25

covering this stock

Price Range

$37 - $57

Analyst target range

Buy
14 (56%)
Hold
10 (40%)
Sell
1 (4%)

Coverage is broad and moderately bullish: 23 analysts cover Monster with a distribution of 14 Buy, 10 Hold, and 1 Sell, yielding a consensus recommendation of "buy" (recommendation mean 2.04, where lower is more bullish). The average target price is $50.13, which implies roughly +7.9% upside from the current $46.46 price, and the consensus leans constructive but not aggressive — the heavy Hold contingent (10 of 23) reflects the view that the stock is fairly valued after its 30.73% one-year run. Recent institutional actions are notably stable rather than directional: Bernstein reiterated Market Perform on Nov 9, Piper Sandler and Wells Fargo reiterated Overweight on Nov 6, and UBS and JP Morgan maintained Neutral, suggesting analysts are comfortable with existing ratings rather than repositioning.

The target range of $37.00 to $57.00 is wide — a 54% spread from low to high — signaling meaningful disagreement about the growth trajectory. The $57 high target implies roughly 22.7% upside and would require the market to embrace multiple expansion on top of the consensus forward EPS of $1.82, effectively assuming international growth stays above 30% and margins re-expand toward the 31% operating level seen in Q1 2026. The $37 low target implies about 20.4% downside and prices in a scenario where US category deceleration accelerates, competitive pressure from Celsius and others compresses margins, and the premium multiple de-rates toward the low end of its historical band. The wide dispersion, combined with the stock's low 0.511 beta and the fact that the average target sits only ~8% above spot, suggests a fairly-valued quality compounder where the risk/reward is balanced rather than compelling in either direction.

Drowning in data?

Find the real signal!

Bulls vs Bears: MNST Investment Factors

The bull case currently has stronger evidence: 16.65% revenue growth powered by 34.6% international expansion, elite 54.65% gross margins, zero debt, and $1.921 billion in TTM free cash flow are concrete, verifiable strengths that justify a premium multiple. The bear case rests largely on valuation and deceleration risk rather than any deterioration in the business — the 39.12x trailing PE and 28.04% operating margin (down from 31.02% in Q1) are the main cracks. The single most important tension is whether international growth above 30% can persist long enough to grow into the multiple; if it does, the PEG of 1.28 looks reasonable, but if US deceleration accelerates and international cools, a 39x multiple on high-single-digit growth would de-rate sharply toward the $37 low target. With the average analyst target only ~8% above spot and a heavy 10-of-23 Hold contingent, the risk/reward is balanced rather than compelling in either direction.

Bullish

  • International growth engine surging 34.6%: International sales are growing 34.6% and now represent roughly 46% of revenue, giving Monster a geographic runway that most mature beverage peers lack. This is the single biggest driver of the 16.65% Q3 2026 revenue growth, which is well above what a company of this size would normally deliver.
  • Elite margins with pricing power: Gross margin has held in a remarkably stable 54.6%-55.9% band across the last four quarters (Q3 2026 at 54.65%, Q2 at 55.95%, Q1 at 54.96%, Q4 2025 at 55.53%), demonstrating pricing power and input-cost stability. TTM net margin of 22.97% and operating margin of 29.17% are far above legacy soda peers' mid-teens margins.
  • Pristine balance sheet, zero leverage: Debt-to-equity is 0.0, the current ratio is 3.70, and the company holds $2.148 billion in cash. TTM free cash flow of $1.921 billion covers the $31.6 million quarterly capex more than 17x, meaning growth is funded entirely internally.
  • Analyst consensus buy with upside: 23 analysts split 14 Buy / 10 Hold / 1 Sell for a consensus recommendation of 'buy' (mean 2.04), with an average target of $50.13 implying +7.9% upside from $46.46. The $57 high target implies roughly 22.7% upside if international growth stays above 30% and margins re-expand toward the 31% Q1 2026 level.

Bearish

  • Premium 39x PE leaves no room for error: The stock trades at 39.12x trailing and 35.67x forward earnings, with a 9.02x PS and 27.94x EV/EBITDA — roughly a 40-100%+ premium to large-cap beverage peers on sales. If growth decelerates toward high-single digits, a 39x multiple would compress sharply.
  • Operating margin compressing as spend ramps: Operating margin fell from 31.02% in Q1 2026 to 28.04% in Q3 as selling and marketing investment ramps. Q3 net income of $568.4 million was actually down from $584.5 million in Q2 despite higher revenue, a direct function of this margin compression.
  • US category deceleration and Celsius threat: The domestic energy category is showing signs of deceleration while competition from challengers like Celsius intensifies, and roughly two-thirds of revenue still comes from the US and Canada. Celsius's Q2 miss and declining flagship sales signal category-wide growth troubles that could spill over to Monster's core franchise.
  • Thin analyst upside and heavy Hold contingent: The average target of $50.13 sits only ~7.9% above the $46.46 spot price, and 10 of 23 analysts rate the stock a Hold, reflecting a view that it is fairly valued after its 30.73% one-year run. Recent institutional actions were reiterations rather than upgrades, suggesting analysts are comfortable, not adding.

MNST Technical Analysis

Monster is in a sustained, if choppy, uptrend: shares are up 30.73% over the past year versus a 12.27% gain for SPY, a relative strength advantage of 18.46 percentage points, and the current price of $46.46 sits at roughly 74.4% of the 52-week range bounded by a $35.43 low and $50.17 high. That positioning — well above the midpoint but not pinned to the highs — suggests a stock with positive momentum that has already digested a meaningful re-rating rather than one that is either overextended at the ceiling or broken down near the floor. The 22.01% YTD gain and 6.69% six-month advance confirm the longer-term trend remains constructive despite periodic pullbacks.

Short-term momentum is re-accelerating after a mid-year stall: the stock is up 5.07% over the past month versus a 2.26% decline for SPY, a 7.33-point relative strength spread, and the most recent session added 1.95% on a close of $46.46. However, the three-month change of -0.77% is essentially flat and slightly negative, revealing a consolidation phase between the July highs near $49.97 and the late-September lows around $41.62 before the October-November recovery. This divergence — strong 1-month and 1-year performance against a flat 3-month — is characteristic of a mean-reversion pause within an uptrend rather than a trend reversal, and the recent push back above $46 argues the pullback has run its course.

Key technical levels are well defined: support sits at the 52-week low of $35.43, with a nearer intermediate floor around the September trough of $41.62, while resistance is the 52-week high of $50.17, just 8.0% above the current $46.46 price. A breakout above $50.17 would confirm the uptrend and likely trigger momentum-driven buying, whereas a breakdown below $41.62 would signal a failed recovery and put the $35.43 low in play. The stock's beta of 0.511 is a critical risk-management input — Monster is roughly half as volatile as the S&P 500, meaning it offers defensive characteristics and smaller drawdowns (max drawdown of -17.7% over the period) but also implies that its 30.73% one-year gain was achieved with far less market-driven beta, underscoring the role of idiosyncratic fundamentals in the move.

Beta

0.51

0.51x market volatility

Max Drawdown

-17.7%

Largest decline past year

52-Week Range

$35-$50

Price range past year

Annual Return

+30.7%

Cumulative gain past year

PeriodMNST ReturnS&P 500
1m+5.1%-1.2%
3m-0.8%-2.4%
6m+6.7%+2.8%
1y+30.7%+12.3%
ytd+22.0%+10.6%

Bobby - Your AI Investment Partner

Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions

MNST Fundamental Analysis

Monster's revenue trajectory is clearly accelerating: Q3 2026 revenue of $2.563 billion grew 16.65% year over year, building on a sequential climb from $2.353 billion in Q1 and $2.537 billion in Q2, and comparing favorably to the $2.197 billion reported in Q3 2025. The segment mix shows Monster Energy Drinks at $2.373 billion dominating the top line, with Strategic Brands at $156.4 million and Alcohol Brands at just $28.5 million, meaning the core energy franchise is doing essentially all of the heavy lifting. The growth is being powered disproportionately by international markets (up 34.6% and now ~46% of revenue), which is the key bull case — it implies the company still has geographic runway even as the mature US category decelerates, and the 16.65% growth rate is well above what a company of this size would normally deliver.

Profitability is robust and improving: Q3 2026 net income was $568.4 million on a 22.18% net margin, with gross margin of 54.65% and operating margin of 28.04%, and the trailing-twelve-month net margin stands at 22.97% with a 55.85% gross margin and 29.17% operating margin. Gross margin has been remarkably stable in the 54.6%-55.9% band across the last four quarters (Q2 2026 was 55.95%, Q1 2026 54.96%, Q4 2025 55.53%), indicating pricing power and input-cost stability, while operating margin has compressed modestly from 31.02% in Q1 2026 to 28.04% in Q3 as selling and marketing investment ramps. Net income of $568.4 million in Q3 was actually down slightly from $584.5 million in Q2 despite higher revenue, a function of the margin compression, but the absolute profitability remains elite for a beverage company and the 23.08% ROE confirms strong capital efficiency.

Financial health is pristine: debt-to-equity is 0.0 (the company carries essentially no debt), the current ratio is a very liquid 3.70, and trailing free cash flow is $1.921 billion, with Q3 2026 FCF of $525.0 million generated from $556.6 million in operating cash flow against only $31.6 million of capex. The balance sheet holds $2.148 billion in cash, and the company is returning capital via $100.4 million of Q3 share repurchases while also deploying cash into investments ($830.9 million of purchases in Q3). With zero leverage, a 3.70 current ratio, and FCF covering capex more than 17x, Monster funds growth entirely internally — the financial risk here is minimal, and the main capital-allocation question is whether buybacks at a ~39x P/E are the best use of cash.

Quarterly Revenue

$2.6B

2026-09

Revenue YoY Growth

+16.7%

YoY Comparison

Gross Margin

54.6%

Latest Quarter

Free Cash Flow

$1.9B

Last 12 Months

Revenue & Net Income Trends (2 Years)

Revenue Breakdown

Monster Energy Drinks
Alcohol Brands
Strategic Brands

Open an Account, get $2 TSLA now!

Valuation Analysis: Is MNST Overvalued?

Because Monster is solidly profitable (Q3 2026 net income of $568.4 million; TTM net margin 22.97%), the PE ratio is the appropriate primary metric. The stock trades at 39.12x trailing earnings and 35.67x forward earnings, and the roughly 3.5-turn gap between trailing and forward multiples implies the market expects meaningful EPS growth — consistent with the consensus forward EPS estimate of $1.82 versus the current run-rate. A 39x trailing PE for a company growing revenue 16.65% is a growth-stock multiple, not a defensive-staples multiple, and the PEG ratio of 1.28 suggests the growth partially but not fully justifies the premium.

Relative to the broader consumer staples/beverages landscape, Monster's 9.02x PS, 9.11x EV/Sales, and 27.94x EV/EBITDA represent a substantial premium — a typical large-cap beverage peer trades in the high-teens to low-20s EV/EBITDA and 2-4x sales, implying Monster commands roughly a 40-100%+ premium on sales and a meaningful premium on EBITDA. That premium is defensible on growth (16.65% revenue growth and 23% net margins versus low-single-digit growth and mid-teens margins for legacy soda peers) but leaves little room for error; the 9.07x P/B and 35.66x P/CF further underscore how much optimism is embedded. The PEG of 1.28 is the most reassuring datapoint — it is not egregious for a franchise with this growth and margin profile.

Historically, Monster's own valuation band has been wide: PE ranged from roughly 30.4x (Q2 2024) to 46.9x (Q4 2024) over the past two years, with the current 39.12x sitting in the upper-middle of that range, while PS has ranged from about 27.0x to 37.1x and now sits at 9.02x on the current share count basis (post-split adjusted figures differ from the historical per-share series). The current multiple is neither at the euphoric top of its own band nor at a trough — it reflects a market that is pricing in continued international-driven growth but has already de-rated from the ~47x peak seen in late 2024. The key risk is that if growth decelerates toward the high-single digits, a 39x multiple would compress sharply; the key upside is that sustained mid-teens growth keeps the PEG attractive and supports the multiple.

PE

39.1x

Latest Quarter

vs. Historical

Mid-Range

5-Year PE Range 30x~47x

vs. Industry Avg

31.5x

Industry PE ~31.5x*

EV/EBITDA

27.9x

Enterprise Value Multiple

Investment Risk Disclosure

Financial and operational risks are modest but not zero. The company carries essentially no debt (debt-to-equity of 0.0) and a 3.70 current ratio, so solvency is not a concern; the real financial risk is margin compression, with operating margin falling from 31.02% in Q1 2026 to 28.04% in Q3 as selling and marketing spend ramps, and Q3 net income of $568.4 million declining from $584.5 million in Q2 despite higher revenue. Revenue concentration is another factor: Monster Energy Drinks at $2.373 billion of the $2.563 billion Q3 total means the core franchise does essentially all the heavy lifting, while Alcohol Brands contribute just $28.5 million. The valuation itself is a financial risk — at 39.12x trailing earnings, the stock depends on continued mid-teens growth to justify its multiple, and buybacks at that level ($100.4 million in Q3) may not be the highest-return use of cash. Market and competitive risks center on valuation compression and category dynamics. At 9.02x PS and 27.94x EV/EBITDA, Monster trades at roughly a 40-100%+ premium to large-cap beverage peers, leaving little cushion if growth slows; the PEG of 1.28 offers only partial justification. Competition from Celsius and other challengers is intensifying even as the US energy category decelerates, and with roughly two-thirds of revenue from the US and Canada, domestic weakness matters. The low 0.511 beta limits market-correlation risk but also means the stock's 30.73% one-year gain was driven by idiosyncratic fundamentals that could reverse independently of the broader market. The worst-case scenario is a chain in which US category deceleration accelerates, Celsius and others take share, marketing spend keeps compressing operating margins below 28%, and international growth cools from 34.6% toward the high teens — a combination that would force the 39x multiple to de-rate toward the low end of its historical band. In that scenario the stock could fall to the $37 analyst low target, roughly -20.4% from the current $46.46, and a deeper de-rating could test the $35.43 52-week low, about -23.7%. The historical max drawdown of -17.7% suggests such a move is well within the realm of recent experience.

FAQ

Ranked by severity: first, valuation compression — at 39.12x trailing earnings and 9.02x sales, a de-rating toward the 30.4x low end of the two-year band alone would take the stock toward the $37 analyst low target, about -20.4% from $46.46. Second, margin erosion — operating margin has already fallen from 31.02% in Q1 2026 to 28.04% in Q3 as selling and marketing spend ramps, and Q3 net income of $568.4 million came in below Q2's $584.5 million despite higher revenue. Third, competitive and category risk — Celsius and other challengers are intensifying pressure just as the US energy category decelerates, and roughly two-thirds of revenue still comes from the US and Canada. Fourth, concentration and growth-dependence — Monster Energy Drinks at $2.373 billion of the $2.563 billion Q3 total means the core franchise carries essentially the entire thesis, and international growth cooling from 34.6% toward the high teens would remove the main justification for the premium multiple.

The 12-month forecast splits into three scenarios. The base case carries 55% probability with a $48-$52 target range, assuming forward EPS of about $1.82 and revenue near $14.14 billion, international growth moderating to the mid-to-high 20s, and the forward multiple holding near 35.67x — landing near the $50.13 average analyst target, roughly +7.9%. The bear case carries 25% probability with a $37-$41.62 range, driven by US deceleration, Celsius share gains, operating margin below 28%, and international growth cooling toward the high teens, with the $41.62 September trough as an intermediate waypoint and the $35.43 low in play in a deeper de-rating. The bull case carries 20% probability with a $55-$57 range, requiring international growth above 30%, operating margin re-expanding toward 31%, and multiple expansion toward the $57 high target. The base case is most likely because it requires only that current trends persist rather than reverse.

Monster screens as fairly valued to modestly full rather than cheap. The primary metric is the PE given solid profitability: 39.12x trailing and 35.67x forward, with a PEG of 1.28 that partially — but not fully — justifies the premium for a company growing revenue 16.65%. On sales and EBITDA the stock is expensive in absolute terms at 9.02x PS, 9.11x EV/Sales, and 27.94x EV/EBITDA, a roughly 40-100%+ premium to large-cap beverage peers that typically trade in the high-teens to low-20s on EV/EBITDA and 2-4x on sales. Against its own history the 39.12x PE sits in the upper-middle of a roughly 30.4x-46.9x two-year band, meaning the market has already de-rated from the ~47x peak of late 2024 but has not reset to trough levels. What the valuation implies is that the market expects international growth to stay above 30% long enough for earnings to grow into the multiple; if growth slips toward high-single digits, a 39x multiple would compress sharply.

From a pure risk/reward standpoint the setup is balanced rather than compelling: at $46.46 the stock sits about 7.9% below the $50.13 average analyst target, while the $37 low target implies roughly 20.4% downside and the $35.43 52-week low implies about 23.7% downside — so the downside is roughly 2.5-3x the consensus upside. The business quality is genuinely high, with 16.65% revenue growth, a 54.65% gross margin, zero debt, and $1.921 billion in TTM free cash flow, and the 0.511 beta plus a -17.7% max drawdown mean the ride is smoother than the market's. But 39.12x trailing and 35.67x forward earnings already discount a lot of that success, and 10 of 23 analysts rate it a Hold. It is a reasonable buy for a long-horizon investor comfortable with a full multiple and willing to add on weakness toward the $41.62 September trough, but it is not a compelling entry at current levels for someone seeking near-term upside.

Monster is better suited to a long-term holding period than to short-term trading. The growth profile — 16.65% revenue growth driven by 34.6% international expansion — is a multi-year runway story, and the zero dividend (payout ratio of 0, dividend yield of 0) means total return depends entirely on earnings growth and multiple change, which favors patience over trading. Volatility is low, with a beta of 0.511 and a max drawdown of only -17.7%, so there is little short-term trading edge from volatility, and the flat three-month change of -0.77% shows how range-bound the stock can be between the $41.62 and $49.97 levels. Earnings visibility is decent given the stable 54.6%-55.9% gross margin band, but the 39x multiple makes the stock sensitive to quarterly margin and international growth prints. A minimum holding period of two to three years is appropriate to let international growth compound into the valuation; short-term traders would be better served waiting for a pullback toward the $41.62 support before establishing a position.